Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-05-03
2005-05-03
Berch, Mark L. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S101000, C544S032000, C540S468000, C540S472000, C540S477000, C540S547000, C540S556000, C540S581000, C546S094000, C548S150000, C548S217000, C548S302400, C548S428000
Reexamination Certificate
active
06887868
ABSTRACT:
The present invention provides compounds of Formula (I):wherein: R1, R2, R3, R4, R5, R6R7, R8, n, m, and X have any of the values defined in the specification, as well as pharmaceutical compositions comprising the compounds. The invention also provides therapeutic methods as well as processes and intermediates useful for preparing compounds of Formula (I). The compounds are 5-HT ligands and are useful for treating diseases wherein modulation of 5-HT activity is desired.
REFERENCES:
patent: 4219550 (1980-08-01), Rajagopalan
patent: 4938949 (1990-07-01), Borch et al.
patent: 2 330 719 (1974-01-01), None
patent: 0 322 016 (1989-06-01), None
patent: 0 393 766 (1990-10-01), None
patent: 0 403 261 (1990-12-01), None
patent: 0 473 550 (1992-03-01), None
patent: WO 0006564 (2000-02-01), None
patent: WO 0064899 (2000-11-01), None
patent: WO 0077010 (2000-12-01), None
Total Synthesis of Heptacyclic Aspidosperma Alkaloids, Part 1, Preliminary Experiments, John W. Blowers, et al., J. Chem. Soc. Perkins Trans. 1 1987, pp. 2079-2090 (12 sheets).
(+)-cis-4, 5, 7a, 8, 9, 10, 11, 11a -Octahydro-7H-10-methylindolo [1, 7-bc] [2,6]-napthyridine: A 5-HT2C/2BReceptor Antagonist with Low 5-HT2AReceptor Affinity, J. Med. Chem., vol. 38, No. 1, 1995, pp. 28-33 (6 sheets).
5-HT6Serotonin Receptor Binding of Indolealkyamines: A Preliminary Structure-Affinity Investigation, Med. Chem. Res., vol. 9, No. 2, 1999, pp. 108-117 (10 sheets).
Berch Mark L.
Flynn ,Thiel, Boutell & Tanis, P.C.
Habte Kahsay
Pharmacia & Upjohn Company
LandOfFree
Therapeutic 5-HT ligand compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Therapeutic 5-HT ligand compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic 5-HT ligand compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3390412